Core Viewpoint - The company is proceeding with the sale of a 30% stake in its associate company, Zhongke Bosheng Silicon Material Technology Co., Ltd., as part of its overall business strategy to focus on core operations and optimize its business layout [1][4]. Group 1: Meeting and Decision - The independent directors' special meeting was held on August 11, 2025, in Wuhan, with all three independent directors present, complying with relevant regulations [1]. - The meeting reviewed the proposal for the sale of equity in the associate company, which was previously approved in a board meeting on September 29, 2024 [1]. Group 2: Sale Process - The first public tender for the 30% stake in Zhongke Bosheng was announced on July 2, 2025, with an initial investment value of RMB 15 million, setting the sale price at the same amount [2]. - After the first tender failed, the company decided to adjust the sale price to RMB 10.9281 million based on an asset evaluation report dated December 31, 2024 [2]. - The second tender, announced on July 29, 2025, also failed to attract sufficient bidders, leading to negotiations with Ningbo Huining Investment Co., Ltd. to sell the stake at the evaluated price [3]. Group 3: Approval and Rationale - The independent directors unanimously agreed that the sale aligns with the company's business strategy and does not harm the interests of the company or its shareholders, particularly minority shareholders [4]. - The decision to proceed with the sale was supported by a vote of 3 in favor, with no opposition or abstentions [4].

汇绿生态科技集团股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 汇绿生态科技集团股份有限公司（以下简称"公司"或"汇绿生态"）第十 一届董事会第十次会议于 2025 年 8 月 7 日以书面方式通知各位董事，于 2025 年 室、浙江省宁波市北仑区长江路 1078 号好时光大厦 1 幢 18 楼公司会议室以现场 方式召开。会议由董事长李晓明先生召集并主持。会议应出席董事 9 名，实际出 席董事 9 名。公司高管列席了本次会议，董事李晓明先生、刘斌先生、彭开盛先 生因工作原因以通讯方式参会。 本次会议的召集和召开符合《公司法》 《公司章程》等有关法律、行政法规、 部门规章、规范性文件和的有关规定，合法、有效。 二、董事会会议审议情况 经与会董事审议，会议形成了如下决议： 证券代码：001267 证券简称：汇绿生态 公告编号：2025-072 鉴于第一次招标失败，经公司总经理办公会讨论，同意转让价格参照深圳国 誉资产评估房地产土地估价顾问有限公司以 2024 年 12 月 31 日为评估基准日所 出具的《资产评估报告》（深国誉 ...

证券代码：001267 证券简称：汇绿生态 公告编号：2025-073 汇绿生态科技集团股份有限公司 本公司及监事会全体成员保证信息披露内容的真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、监事会会议召开情况 汇绿生态科技集团股份有限公司（以下简称"公司"）第十一届监事会第七次会议 于 2025 年 8 月 7 日以书面方式通知各位监事，会议于 2025 年 8 月 11 日在湖北省武汉 市江汉区青年路 556 号房开大厦写字楼 37 楼公司会议室、浙江省宁波市北仑区长江路 集并主持，会议应出席监事 5 名，实际出席监事 5 名。 公司第一次公开对参股公司中科博胜 30%股权招标处置项目于 7 月 2 日在《湖北省 成套招标股份有限公司》(http://www.hubeibidding.com)及 2025 年 7 月 3 日《国际商报》 发布了招标公告，公司投资中科博胜原股权投资价值为人民币 1500 万元，故出售价格 为人民币 1500 万元。截止至 2025 年 7 月 8 日下午 16：30，无单位报名，项目流标。 鉴于第一次招标失败，经公司总经理办公会讨论，同意转让价格参照深圳国誉资产 ...

Core Viewpoint - The company has agreed to sell a 30% stake in its associate company, Fujian Zhongke Bosheng Silicon Material Technology Co., Ltd., for an assessed price of 10.9281 million yuan, after previous attempts to auction the stake failed [1] Group 1: Transaction Details - The original investment value of the 30% stake was 15 million yuan [1] - The stake will be transferred to Ningbo Huining Investment Co., Ltd., a related party and an action-in-concert with the major shareholder [1] - The transaction is classified as a related party transaction but not a major asset restructuring [1] Group 2: Board Approval - The independent directors believe that this move will help the company focus on its core business and that the pricing is fair [1] - The proposal was submitted to the company's 11th Board of Directors for review, with a voting result of 3 votes in favor, 0 against, and 0 abstentions [1]

Core Viewpoint - Delijia Transmission Technology (Jiangsu) Co., Ltd. has submitted its IPO registration after over 7 months of waiting, marking a significant step towards listing on the A-share market [1][3]. Company Overview - Delijia specializes in the research, production, and sales of high-speed heavy-duty precision gear transmission products, primarily serving the wind power generation sector with its core product being the wind turbine main gearbox [1][3]. IPO Details - The company aims to raise approximately 1.88 billion yuan through the IPO, which will be allocated to projects including the annual production of 1,000 units of 8MW and above large onshore wind power gearboxes and an annual production of 800 units of large offshore wind power gearboxes in Shantou [3]. Financial Performance - From 2021 to 2023, Delijia experienced growth in both revenue and net profit, but forecasts indicate a decline in both metrics for 2024, with expected revenue of about 3.715 billion yuan and a net profit of approximately 534 million yuan [3]. - In the first half of 2025, the company reported revenue of about 2.487 billion yuan, reflecting an 81.29% year-on-year increase, and a net profit of approximately 393 million yuan, up 67.56% year-on-year [3]. Related Transactions - Delijia has a high proportion of related party transactions, with significant sales to major clients such as Sany Renewable Energy and Envision Energy, which accounted for 37.39%, 45.43%, and 43.56% of sales from 2022 to 2024 [4][5]. - The company’s revenue is heavily reliant on its top five customers, with sales to these clients representing 98.86%, 95.92%, and 94.73% of total revenue from 2022 to 2024 [6]. Customer Dependency - The company faces risks associated with high customer concentration, as over 90% of its revenue comes from its top five clients, primarily due to the concentrated nature of the wind power equipment manufacturing industry [6].

Core Viewpoint - Xiangdian Co., Ltd. plans to acquire 12.5% equity of Tongda Electromagnetic Co., Ltd. from its controlling shareholder, Xiangdian Group, for 208 million yuan, amidst concerns over long-term related party transactions and the financial health of Xiangdian Group [1][2]. Group 1: Acquisition Details - The acquisition is valued at 208 million yuan, with a total equity value of Tongda Electromagnetic assessed at 1.664 billion yuan, reflecting a 60.09% appreciation [4]. - The price-to-earnings ratio for the acquisition is notably high at 46 times, based on Tongda Electromagnetic's projected net profit of 36.18 million yuan for 2024 [4]. Group 2: Related Party Transactions - Over the past decade, Xiangdian Co. has engaged in related party transactions exceeding 2.4 billion yuan, including over 1.5 billion yuan in acquisitions and more than 900 million yuan in asset sales to related parties [4]. - Historical transactions have raised concerns about potential harm to minority shareholders, with instances of Xiangdian Group acquiring shares at undervalued prices [4][6]. Group 3: Financial Health of Xiangdian Group - Xiangdian Group has faced significant financial challenges, with a debt ratio reaching 98.87% and a current ratio of 0.68, indicating high debt pressure [6]. - As of December 31, 2021, Xiangdian Group reported total assets of 15.379 billion yuan and a net asset value of 1.808 billion yuan, with a debt ratio of 88.24% [6]. Group 4: Company Performance and Financing - Since its IPO in 2002, Xiangdian Co. has accumulated a net loss of 1.266 billion yuan while raising 10.924 billion yuan through direct financing, with total dividends amounting to only 474 million yuan [8]. - The company has announced a new round of financing plans to raise 2 billion yuan for various projects, although the effectiveness of this financing in improving operational and financial conditions remains uncertain [9][10].

Core Viewpoint - Xiangdian Co., Ltd. plans to acquire 12.5% of Tongda Electromagnetic Co., Ltd. from its controlling shareholder, Xiangdian Group, for 208 million yuan, amidst concerns over past related-party transactions and the financial health of Xiangdian Group [1][2]. Group 1: Acquisition Details - The acquisition price for Tongda Electromagnetic is based on a valuation of 1.664 billion yuan, reflecting a 60.09% increase in value [2]. - The projected price-to-earnings ratio for Tongda Electromagnetic based on its 2024 net profit of 36.18 million yuan is 46 times [2]. Group 2: Historical Related-Party Transactions - Over the past decade, Xiangdian Co. has engaged in related-party transactions exceeding 2.4 billion yuan, including over 1.5 billion yuan in acquisitions from Xiangdian Group and over 900 million yuan in asset sales [2]. - Previous related-party transactions have raised concerns about potential harm to minority shareholders, particularly instances where Xiangdian Group acquired stakes at undervalued prices [5]. Group 3: Financial Health of Xiangdian Group - Xiangdian Group has faced significant financial difficulties, with a debt ratio of approximately 98.87% and a net profit of -12.06 million yuan in 2021 [7]. - As of the end of 2021, Xiangdian Group's total assets were 15.379 billion yuan, with a net asset value of 1.808 billion yuan [7]. Group 4: Company Performance and Challenges - Xiangdian Co. has reported cumulative net losses of 1.266 billion yuan since its IPO, despite raising 10.924 billion yuan through direct financing [11]. - The company experienced significant losses in 2018 and 2019 due to market misjudgments and fraud, leading to a total loss of 19.12 billion yuan in 2018 and 15.79 billion yuan in 2019 [8][9]. - Since 2020, the company has shown slight profitability but has increased its capitalization rate for R&D expenses, which may inflate profit figures [9].

Core Viewpoint - Zhejiang Xianju Pharmaceutical Co., Ltd. has decided to deregister its subsidiary, Xianju County Juhua Financial Services Co., Ltd., due to changes in financial policies and the cessation of its original business operations [1][18]. Group 1: Company Decision - The decision to deregister the subsidiary was approved during the 15th meeting of the 8th Board of Directors and the 10th meeting of the 8th Supervisory Board held on August 10, 2025 [1][24]. - The deregistration does not require approval from the shareholders' meeting as it falls within the decision-making authority of the Board of Directors [2][18]. Group 2: Subsidiary Information - Xianju County Juhua Financial Services Co., Ltd. was established in June 2016 with a registered capital of 50 million yuan, and the company held a 20% stake valued at 10 million yuan [1][2]. - The subsidiary's business primarily involved providing loan turnover services for small and medium-sized enterprises, which has now ceased [18]. Group 3: Financial Impact - The deregistration will not affect the company's business development or profitability, nor will it harm the interests of shareholders, especially minority shareholders [18][20]. - There have been no other related transactions with the controlling shareholder, Xianju County Industrial Investment Development Group Co., Ltd., since the beginning of the year [18]. Group 4: Independent and Supervisory Opinions - The independent directors have reviewed and approved the deregistration proposal, stating it aligns with the company's development needs and does not harm shareholder interests [18][20]. - The supervisory board also agrees with the decision, confirming that the process followed legal and regulatory requirements [20][25].

Core Viewpoint - The company has decided to liquidate its subsidiary, Xianju County Juhua Financial Services Co., Ltd., due to a lack of business activity and changes in financial policies, which aligns with its development needs and does not harm the interests of shareholders [1][8]. Summary by Sections Company Decision - The company held a board meeting on August 10, 2025, where it approved the proposal to liquidate the subsidiary [1]. - The decision was made following the review by independent directors, ensuring compliance with relevant laws and regulations [8]. Subsidiary Information - Xianju County Juhua Financial Services Co., Ltd. was established in June 2016 with a registered capital of 50 million yuan, in which the company held a 20% stake [1]. - The subsidiary's main business, providing loan turnover services for small and medium-sized enterprises, has ceased operations [8]. Financial Data of the Subsidiary - As of December 31, 2024, the subsidiary had total assets of approximately 56.51 million yuan and total liabilities of about 4.20 million yuan [1]. - For the first five months of 2025, the subsidiary reported a net profit of approximately 370,273.45 yuan [1]. Impact on the Company - The liquidation will not affect the company's business development or profitability, nor will it harm the interests of shareholders, especially minority shareholders [8]. - The company has not provided any guarantees or financial support to the subsidiary, ensuring no financial risk from this decision [8]. Independent and Supervisory Opinions - The independent directors and the supervisory board have both expressed support for the liquidation, stating that it is in line with the company's development strategy and does not harm shareholder interests [8].

Core Viewpoint - The company has approved a cash increase investment in Shanghai Haihe Pharmaceutical Research and Development Co., Ltd. with a total amount not exceeding RMB 300 million, aiming to acquire a stake of at least 5% in the company after the financing completion [1][2]. Group 1 - The board meeting was held on August 10, 2025, with all 8 directors present, and the procedures complied with relevant regulations [1]. - The company plans to subscribe for new shares at a price of RMB 4.75 per share, potentially acquiring up to 63.157895 million shares [1][2]. - After the completion of the financing, the company's stake in Haihe Pharmaceutical is expected to be between 5% and 8.09% [1]. Group 2 - The company will sign a subscription agreement with Haihe Pharmaceutical and related parties, which requires approval from the shareholders' meeting [2]. - An independent director meeting was held prior to the board meeting, where the proposal was unanimously approved [2]. - The proposal will be submitted to the shareholders' meeting for further approval [2].